Tag: AI regulations

Browse our exclusive articles!

EU Officials to Meet OpenAI CEO in June to Discuss AI Laws

EU officials plan to meet with OpenAI CEO, Sam Altman in June to discuss AI regulations and implementation roadmap for EU's AI regulations.

ChatGPT CEO Pushes for Headquarters in Europe

OpenAI's CEO Sam Altman is scouting for a European office in compliance with upcoming EU regulations. The decision will impact AI regulation enforcement.

OpenAI Might Leave EU due to AI Regulations

OpenAI, the AI technology firm behind the groundbreaking AI Text Generator, ChatGPT, has voiced concern over the EU's new AI regulations. These regulations would require AI companies to report the copyrighted material used to train their system. Sam Altman, OpenAI's CEO, supports the formation of an international AI pact for legal oversight to ensure responsible and ethical use of AI technology.

Sam Altman Affirms OpenAI Commitment to the European Union

OpenAI is a world leading AI organization committed to creating trustworthy AI technologies, led by CEO Sam Altman. The company is currently working on adapting AI regulations for the EU while proposing new regulations for AI use in the US. Microsoft has also joined the debate by proposing a new AI agency. OpenAI is also offering grants to research how AI regulations can be democratically decided. Let's ensure the ethical use of AI for all our benefits.

EU Urged By OpenAI’s Chief To Be Proactive in AI Regulation

This article focuses on CEO of OpenAI, Sam Altman's, discussion on proactively regulating AI in the EU, and governance issues with German Chancellor Olaf Scholz. OpenAI is best known for its widely used chatbot ChatGPT. Altman's mission is to promote friendly artificial general intelligence. Co-chaired by Stephen Hawking & Elon Musk, Altman has long been in the tech industry and leads OpenAI as its CEO.

Popular

Tech Evolution: From Obama’s Optimism to Harris’s Vision

Explore the evolution of tech policy from Obama's optimism to Harris's vision at the Democratic National Convention. What's next for Democrats in tech?

Tonix Pharmaceuticals TNXP Shares Fall 14.61% After Q2 Earnings Report

Tonix Pharmaceuticals TNXP shares decline 14.61% post-Q2 earnings report. Evaluate investment strategy based on company updates and market dynamics.

The Future of Good Jobs: Why College Degrees are Essential through 2031

Discover the future of good jobs through 2031 and why college degrees are essential. Learn more about job projections and AI's influence.

Pioneering Research Uncovers Vital Biomarker for Orbital Inflammation

An in-depth study reveals HLF as a potential biomarker for orbital inflammation, offering new insights for diagnosis and treatment strategies.

Subscribe

spot_imgspot_img